Gilead Pharmaceuticals is among the largest pharmaceutical companies in the world, and it has earned over $200 billion in profits.
However, that money was all but wiped out by a combination of mergers and acquisitions.
The company has made a total of over $8 billion in total compensation to employees over the last 20 years, with the majority of that money going to the CEOs of the company’s major global drugmakers.
As a result, Gileads payouts for employees with more than one job are often quite large.
According to a recent report by the company, the average Gileader employee receives $1,600 per year in compensation, with some employees receiving more than $5,000.
That is more than double the average payout to the average U.S. full-time employee.
Gileaders CEO Stephen Elop is quick to point out that Gileades payouts are not tied to how many people are on the payroll, but instead to the number of employees that are actually working at the company.
He also claims that employees who make over $1 million per year will be paid an average of $3,000 more per year than their counterparts who make less than that amount.
In fact, the CEO says that most of the CEO’s compensation has been driven by the number and type of people that are on their payroll.
GILEAD is not the only company in this category.
Other companies that have made huge payouts in the past few years include Pfizer ($1.3 billion), Pfizer Plc ($1 billion), and Johnson & Johnson ($1 million).
Most of the companies that received the largest payouts this year were pharmaceutical companies.
As we mentioned in the article about the payouts of CEOs, these payouts come out of the pockets of executives at companies that profit from the drugs they sell.
The payouts aren’t just made in the name of profits, either.
They are made for the health and well-being of their workers.
Gildan is the latest company to take advantage of the soaring cost of prescription drugs to make huge payoffs to its executives.
This year, the company announced a $2.4 billion payout to its chief executive officer.
The CEO of Gilden was paid $3.8 million, while the CEO of Amgen received $4.6 million.
The largest payout to any individual at Gildens was to its president, who received $7.5 million.
Gila International was also the recipient of the largest payout, receiving $8.1 million.
All of these payoffs came after a period in which pharmaceutical companies started to negotiate higher drug prices and the companies started cutting back on the number, types, and lengths of contracts with their employees.
Giliad is one of the most aggressive payers in the industry.
Its CEO, David Gileady, has made over $15 billion in salary and bonuses.
According, Gildayad paid its CEO a total compensation package of $5.4 million in 2016, with a total payout of $2,851,723.
The top 10 earners on Gildad’s 2016 list were: CEO David Gildady (paid $5 billion) President Michael B. Johnson (paid more than twice that amount) President and CEO of Merrimack Pharmaceuticals, Michael S. Johnson, Jr. (paid over $5 million) Chairman and CEO Emeritus of Johnson & Johnson, David C. Johnson Jr. CEO and Chairman of Merrell, Thomas R. Lippincott, Jr., President and Chief Executive Officer of Merrifields, Thomas C. Moffett, Jr.(paid over three times that amount).
Other companies to make large payouts This is just the tip of the iceberg when it comes to the staggering amount of payouts made by Gildads CEO and his executives.
The majority of the paychecks are made by people who are either paid for service to the company or for the work that they do.
Gilady also has a reputation for making outlandish payouts.
According the company website, his base salary is $2 million per annum.
He received $3 million in 2017 and $4 million last year.
He is also the CEO and chairman of a healthcare conglomerate called Gileado that has received more than four times the number in the same period as Gildafys salary.
Giles chief executive, Stephen Elan, has also been very vocal about the amount of money that his company is taking from its employees.
In 2017, he said that his pay would be around $2 billion for the year, but that it would be even more in 2018.
In his most recent interview with CNBC, Elan claimed that he would be worth $5 to $10 billion, and that he is looking to increase his pay in the future.